#Influenza and Other Respiratory Viruses Research #References (AMEDEO, August 29 '26)

 

BMC Pediatr

1. ROHDE G, Haraldstad K, Helseth S, Hagen M, et al
   Health-related quality of life in parents of adolescents in 2019, 2021 and 2023.
   BMC Pediatr. 2026;26:783.
   PubMed         Abstract available
   
   
2. ZHU L, Zeng L, Zhang M, Chen X, et al
   Comparison of human metapneumovirus and respiratory syncytial virus in children with acute lower respiratory infections in Wenzhou, China from 2021 to 2022: a retrospective study.
   BMC Pediatr. 2026;26:774.
   PubMed         Abstract available
   
   

   
   J Immunol

3. DICK JK, Krishna VD, Hicks D, Sangala JA, et al
   ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.
   J Immunol. 2026;215:vkag235.
   PubMed         Abstract available
   
   

   
   J Virol

4. ALYMOVA IV, Mekonnen B, Wang D, Kamal RP, et al
   N-linked glycosylation sites with low occupancy support sustained circulation of the A(H3N2) influenza A virus in the human population.
   J Virol. 2026 Aug 28:e0066226. doi: 10.1128/jvi.00662.
   PubMed         Abstract available
   
   
5. BARRE RS, Nath H, Nogales A, Abdelwhab EM, et al
   NS-segment-based reporter influenza A viruses: engineering strategy, applications, and limitations.
   J Virol. 2026 Aug 26:e0109926. doi: 10.1128/jvi.01099.
   PubMed         Abstract available
   
   

   
   PLoS Comput Biol

6. KENNEDY J, Ferguson W, Jones O, Riley S, et al
   Evaluation of short-term multi-target respiratory forecasts over winter 2024-25 in England using sub-ensemble contribution analyses.
   PLoS Comput Biol. 2026;22:e1014644.
   PubMed         Abstract available
   
   
7. OSTHUS D, Murph AC, Goldberg EE, Beesley LJ, et al
   Leveraging synthetic and genetic data to improve epidemic forecasting.
   PLoS Comput Biol. 2026;22:e1014630.
   PubMed         Abstract available
   
   

   
   PLoS One

8. HO QM, Duong BT, Nguyen LNT, Susilawati TN, et al
   ICU admission and mortality in adult patients with influenza A(H1N1)pdm09-related pneumonia in Vietnam since the 2009 H1N1 pandemic: A 10-year cohort study.
   PLoS One. 2026;21:e0348450.
   PubMed         Abstract available
   
   
9. NASH RK, Bhatia S, Wardle J, Cori A, et al
   Forecasting COVID-19 cases in US states using reconstructed incidence data.
   PLoS One. 2026;21:e0353983.
   PubMed         Abstract available
   
   
10. ARTEMCHUK O, Chakhunashvili G, Finci I, Rojas M, et al
    Factors associated with influenza vaccine uptake among healthcare workers in Georgia, 2021-2024.
    PLoS One. 2026;21:e0356495.
    PubMed         Abstract available
    
    
11. MENDOZA-VELAZQUEZ A, Lara-Arevalo J, Mendoza-Martinez L, Drewnowski A, et al
    Rising food prices and widening nutrition gaps in Mexico: The cost of nutrient-dense and ultra-processed foods before, during, and after COVID-19.
    PLoS One. 2026;21:e0355198.
    PubMed         Abstract available
    
    
12. OVERBOSCH FW, Waltz CNM, Cesuroglu T, Blokland B, et al
    Exploring integrated advice and avian influenza knowledge gaps by using a Highly Pathogenic Avian Influenza outbreak simulation.
    PLoS One. 2026;21:e0354920.
    PubMed         Abstract available
    
    
13. SHARMA S, Elhassan H, Anderson KK, Heisel MJ, et al
    Changes in mental health outcomes of middle-aged and older adults during the COVID-19 pandemic: A scoping review.
    PLoS One. 2026;21:e0342140.
    PubMed         Abstract available
    
    
14. EKHOLUENETALE M
    Decomposing socioeconomic inequalities in COVID-19 vaccination uptake among Nigerian women of reproductive age: A further analysis of population-based data.
    PLoS One. 2026;21:e0357171.
    PubMed         Abstract available
    
    
15. PUEBLA G, Ferrer-Urbina R, Perez-Zapata D, Alarcon-Castillo K, et al
    Cognitive load and individual differences as drivers of health-related misinformation: A signal detection approach.
    PLoS One. 2026;21:e0356642.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

16. RIUMINA ED, Alekseeva EI, Klink GV, Feigin S, et al
    HLA class I escape drives the evolution of SARS-CoV-2 in human populations.
    Proc Natl Acad Sci U S A. 2026;123:e2619192123.
    PubMed         Abstract available
    
    
17. LIU Q, Chen P, He C, Qiu Z, et al
    SESN1 is a negative regulator of MAVS and dynamically expressed during RNA viral infection.
    Proc Natl Acad Sci U S A. 2026;123:e2621443123.
    PubMed         Abstract available
    
    
18. MONTGOMERIE I, McKenzie RE, Palmer OR, Mason NC, et al
    Engineering antigenic breadth against SARS-CoV-2 by pairing divergent RBDs within a single mRNA immunogen.
    Proc Natl Acad Sci U S A. 2026;123:e2602574123.
    PubMed         Abstract available
    
    

    
    Vaccine

19. KOONIN LM, Velez SD, Bresee JS
    Expanding adult immunization in low- and middle-income countries through pharmacist-provided vaccination.
    Vaccine. 2026;90:129004.
    PubMed         Abstract available
    
    
20. KAZENZA B, Masokolo B, Mbunga B, Egbende L, et al
    Why COVID-19 vaccination struggled in the Democratic Republic of Congo: a qualitative study exploring organizational and sociocultural barriers, 2025.
    Vaccine. 2026;90:129033.
    PubMed         Abstract available
    
    
21. HUIBERTS AJ, Eggink D, de Gier B, Karens T, et al
    Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands.
    Vaccine. 2026;90:129030.
    PubMed         Abstract available
    
    
22. HUTTON DW, Prosser LA, Ortega-Sanchez IR, Leidner AJ, et al
    Evaluating the cost-effectiveness of respiratory syncytial virus vaccination among risk-stratified older adults.
    Vaccine. 2026;90:129023.
    PubMed         Abstract available
    
    
23. PORTILHO AI, Andreata-Santos R, Duarte-Barbosa M, Chaves APC, et al
    Functional neutralizing and bactericidal antibody responses induced by dual-target immunization with SARS-CoV-2 RBD and Neisseria meningitidis antigens in mice.
    Vaccine. 2026;90:129011.
    PubMed         Abstract available
    
    
24. AHI T, Andersen KM, Mateus JS, Yu T, et al
    2024-2025 BNT162b2 KP.2 COVID-19 full season vaccine effectiveness from vaccine registries linked to administrative claims in two states: A cohort study in non-immunocompromised adults.
    Vaccine. 2026;90:129009.
    PubMed         Abstract available
    
    
25. LIU X, Cloughesy JN, Yu T, Ferranna M, et al
    Uptake of the RSVpreF vaccine during pregnancy: associations with socioeconomic status, prenatal care utilization, and maternal risk factors.
    Vaccine. 2026;90:129003.
    PubMed         Abstract available
    
    
26. KAZI F, Shapland CY, Spiga F, Villanueva G, et al
    Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant.
    Vaccine. 2026;90:128993.
    PubMed         Abstract available
    
    
27. HUIBERTS AJ, Smits MMJ, Hoeve CE, de Melker HE, et al
    Association between post-vaccination adverse events and subsequent COVID-19 booster uptake in the Netherlands.
    Vaccine. 2026;90:129043.
    PubMed         Abstract available
    
    
28. GENSOROWSKY D, Surmann B, Meyer AC, Poshtiban A, et al
    Corrigendum to "Outpatient care intensity and influenza vaccination: evidence from Germany" [Vaccine 70 (2026) 128038].
    Vaccine. 2026;90:129062.
    PubMed        
    
    
29. BOTT L, Liu J, Challenger A, Powell E, et al
    Myth-busting influenza and fear of adverse reactions in healthcare workers: two experimental studies on vaccination intentions.
    Vaccine. 2026;91:129086.
    PubMed         Abstract available